Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
Yimer SA, Booij BB, Tobert G, Hebbeler A, Oloo P, Brangel P, L'Azou Jackson M, Jarman R, Craig D, Avumegah MS, Mandi H, Endy T, Wooden S, Clark C, Bernasconi V, Shurtleff A, Kristiansen PA. Yimer SA, et al. Among authors: jarman r. BMJ Glob Health. 2024 Apr 30;9(4):e014386. doi: 10.1136/bmjgh-2023-014386. BMJ Glob Health. 2024. PMID: 38688565 Free article. Review.
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.
Lyke KE, Chua JV, Koren M, Friberg H, Gromowski GD, Rapaka RR, Waickman AT, Joshi S, Strauss K, McCracken MK, Gutierrez-Barbosa H, Shrestha B, Culbertson C, Bernal P, De La Barrera RA, Currier JR, Jarman RG, Edelman R. Lyke KE, et al. Among authors: jarman rg. Lancet Infect Dis. 2024 Apr 25:S1473-3099(24)00100-2. doi: 10.1016/S1473-3099(24)00100-2. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38679035
Antigenic distance between primary and secondary dengue infections correlates with disease risk.
Wang L, Huang AT, Katzelnick LC, Lefrancq N, Escoto AC, Duret L, Chowdhury N, Jarman R, Conte MA, Berry IM, Fernandez S, Klungthong C, Thaisomboonsuk B, Suntarattiwong P, Vandepitte W, Whitehead SS, Cauchemez S, Cummings DAT, Salje H. Wang L, et al. Among authors: jarman r. Sci Transl Med. 2024 Apr 24;16(744):eadk3259. doi: 10.1126/scitranslmed.adk3259. Epub 2024 Apr 24. Sci Transl Med. 2024. PMID: 38657027
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Waickman AT, Newell K, Lu JQ, Fang H, Waldran M, Gebo C, Currier JR, Friberg H, Jarman RG, Klick MD, Ware LA, Endy TP, Thomas SJ. Waickman AT, et al. Among authors: jarman rg. Nat Microbiol. 2024 Apr 1. doi: 10.1038/s41564-024-01668-z. Online ahead of print. Nat Microbiol. 2024. PMID: 38561497
Normology: Is it Time to Rethink Point-of-Care Ultrasound Training?
Dupriez F, Jarman RD. Dupriez F, et al. Among authors: jarman rd. J Med Educ Curric Dev. 2024 Feb 12;11:23821205241232498. doi: 10.1177/23821205241232498. eCollection 2024 Jan-Dec. J Med Educ Curric Dev. 2024. PMID: 38357688 Free PMC article.
Antigenic diversity and dengue disease risk.
Wang L, Huang AT, Katzelnick LC, Lefrancq N, Escoto AC, Duret L, Chowdhury N, Jarman R, Conte MA, Berry IM, Fernandez S, Klungthong C, Thaisomboonsuk B, Suntarattiwong P, Vandepitte W, Whitehead S, Cauchemez S, Cummings DAT, Salje H. Wang L, et al. Among authors: jarman r. Res Sq [Preprint]. 2023 Aug 2:rs.3.rs-3214507. doi: 10.21203/rs.3.rs-3214507/v1. Res Sq. 2023. PMID: 37577717 Free PMC article. Preprint.
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.
Sankhala RS, Dussupt V, Donofrio G, Gromowski GD, De La Barrera RA, Larocca RA, Mendez-Rivera L, Lee A, Choe M, Zaky W, Mantus G, Jensen JL, Chen WH, Gohain N, Bai H, McCracken MK, Mason RD, Leggat D, Slike BM, Tran U, Jian N, Abbink P, Peterson R, Mendes EA, Freitas de Oliveira Franca R, Calvet GA, Bispo de Filippis AM, McDermott A, Roederer M, Hernandez M, Albertus A, Davidson E, Doranz BJ, Rolland M, Robb ML, Lynch RM, Barouch DH, Jarman RG, Thomas SJ, Modjarrad K, Michael NL, Krebs SJ, Joyce MG. Sankhala RS, et al. Among authors: jarman rg. Cell Rep. 2023 Aug 29;42(8):112942. doi: 10.1016/j.celrep.2023.112942. Epub 2023 Aug 9. Cell Rep. 2023. PMID: 37561630 Free PMC article.
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Koren MA, Lin L, Eckels KH, De La Barrera R, Dussupt V, Donofrio G, Sondergaard EL, Mills KT, Robb ML, Lee C, Adedeji O, Keiser PB, Curley JM, Copeland NK, Crowell TA, Hutter JN, Hamer MJ, Valencia-Ruiz A, Darden J, Peel S, Amare MF, Mebrahtu T, Costanzo M, Krebs SJ, Gromowski GD, Jarman RG, Thomas SJ, Michael NL, Modjarrad K. Koren MA, et al. Among authors: jarman rg. Lancet Infect Dis. 2023 Oct;23(10):1175-1185. doi: 10.1016/S1473-3099(23)00192-5. Epub 2023 Jun 27. Lancet Infect Dis. 2023. PMID: 37390836 Free PMC article. Clinical Trial.
281 results